Floatz logo

IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER

Juvenile Myelomonocytic Leukemia (JMML)

Diane Georgemonoclonal_antibodyPhase 2Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

28 Active assets in the Juvenile Myelomonocytic Leukemia (JMML) cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 4BBB
Thiotepa
St. Jude Children's Research Hospital
Phase 3BBB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 4BBB
Fludarabine
Children's Oncology Group
Phase 3BB
CYCLOSPORIN A
Case Comprehensive Cancer Center
Phase 3BB

View all 46 →

Same molecule, other indications

IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:

relapsing-remitting multiple sclerosisDormant
BBB
Indicative ·
73 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
71 / 100
View asset →
chronic myeloid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →